EDWARD M. ARNETT,

Duke University,

Chair

W. EMMETT BARKLEY,

Howard Hughes Medical Institute

PETER BEAK,

University of Illinois at Urbana-Champaign

EDWIN D. BECKER,

National Institutes of Health

HENRY E. BRYNDZA,

E.I. du Pont de Nemours & Co.

IMOGENE L. CHANG,

Cheyney University

CAROL CREUTZ,

Brookhaven National Laboratory

RICK L. DANHEISER,

Massachusetts Institute of Technology

ERIC M. GORDON,

Affymax Research Institute

ROBERT J. LACKMEYER,

C/VS Inc.

LEE MAGID,

University of Tennessee at Knoxville

THOMAS F. McBRIDE,

U.S. Department of Energy

ANN M. NORBERG,

3M

EDWARD W. PETRILLO,

Bristol-Myers Squibb

STANLEY H. PINE,

California State University at Los Angeles

FAY M. THOMPSON,

University of Minnesota

TAMAE MAEDA WONG, Study Director

KASANDRA GOWEN, Project Assistant

SARAH W. PLIMPTON, Editorial Assistant

JENNIFER F. BUTERA, Project Assistant

RICK L. DANHEISER,

Massachusetts Institute of Technology,

Chair

W. EMMETT BARKLEY,

Howard Hughes Medical Institute

PETER BEAK,

University of Illinois at Urbana-Champaign

JAMES A. BOND,

Chemical Industry Institute of Toxicology

WILLIAM M. HAYNES,

Monsanto Co.

CURTIS D. KLAASSEN,

University of Kansas

EDWARD W. PETRILLO,

Bristol-Myers Squibb

CHARLES F. REINHARDT,

E.I. du Pont de Nemours & Co.

PHILIP G. WATANABE,

Dow Chemical Co.

ROBERT J. LACKMEYER,

C/VS Inc.,

Chair

DALE T. HITCHINGS,

Hitchings Associates, P.C.

JOHN S. NELSON,

Affiliated Engineers Inc.

EDWIN D. BECKER,

National Institutes of Health,

Chair

PATRICIA A. BAISDEN,

Lawrence Livermore National Laboratory

THOMAS F. CECICH,

Glaxo Inc.

ERIC M. GORDON,

Affymax Research Institute

PETER A. REINHARDT,

University of Wisconsin at Madison